Lan Zhang
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 26
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 35
- Molecular Biology top 1%
- RNA modifications and cancer 26
- Epidemiology top 1%
- Autophagy in Disease and Therapy 38
- Liver Disease Diagnosis and Treatment 17
- Biological Psychiatry top 5%
-
- Cancer Mechanisms and Therapy 17
-
- Alzheimer's disease research and treatments 15
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 14
- Journals
- PLoS ONE (11 papers)European Journal of Medicinal Chemistry (9 papers)Oncotarget (9 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lan Zhang
511 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Cancer Research 1.6k
- Hepatology 812
- Molecular Biology 5.0k
- Epidemiology 1.8k
- Biological Psychiatry 112
Countries citing papers authored by Lan Zhang
This map shows the geographic impact of Lan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Zhang more than expected).
Fields of papers citing papers by Lan Zhang
This network shows the impact of papers produced by Lan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Zhang. The network helps show where Lan Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lan Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 8 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 3 | |
| 13 | 2020 | 10 | |
| 14 | 2018 | 13 | |
| 15 | 2016 | 22 | |
| 16 | 2015 | 51 | |
| 17 | 2014 | 8 | |
| 18 | 2013 | 2 | |
| 19 | [Distribution and normal reference range of fetal nuchal translucency thickness in Kunming pregnant women in the first trimester]. | 2012 | 4 |
| 20 | Effect of 2, 3, 5, 4′-tetrahydroxystilbene-2-o-#beta#-D-glucoside on hippocampal genes expression in mimetic-dementia mice induced by D-galactose | 2005 | 2 |
About Lan Zhang
Lan Zhang is a scholar working on Hepatology, Cancer Research and Molecular Biology, having authored 548 papers that have together received 10.5k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (35 papers), RNA modifications and cancer (26 papers), Cancer-related molecular mechanisms research (26 papers), Liver Disease Diagnosis and Treatment (17 papers), Cancer Mechanisms and Therapy (17 papers), Alzheimer's disease research and treatments (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers). The work is most often cited by research in Cancer Research (1.6k citations), Hepatology (812 citations) and Molecular Biology (5.0k citations). Lan Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Liang Ouyang, Bo Liu, Zhenggang Ren, Shirui Mao, Leilei Fu, Boheng Zhang, Zhijia Li, Xiaoying Xie, Yingying Lü and Yanjun Liu. Their work appears in journals such as PLoS ONE, European Journal of Medicinal Chemistry, Oncotarget, Journal of Medicinal Chemistry and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.